Associate Director, Health Economics & Outcomes Research (HEOR)
BioMarin Pharmaceutical Inc.
August 31, 2026
Remote friendly (San Rafael, CA)
United States
$152,500 - $209,660 USD yearly
Market Access
Summary
The Health Economics & Outcomes Research (HEOR) Associate Director supports asset-specific payer evidence strategies, including patient-relevant outcomes strategy, to generate differentiated evidence, strengthen the payer value proposition, and optimize access across a therapeutic area of interest. Leads patient-relevant outcomes requirements within clinical programs in alignment with Regulatory, HTA and access needs.
Responsibilities
- Lead development, execution and communication of payer evidence strategies for early-stage pipeline assets
- Collaborate with Value & Access, Commercial, Medical Affairs, Clinical Development, Regulatory Affairs, and Patient Advocacy
- Assess payer and HTA requirements for patient-relevant outcomes and health utility measurement
- Ensure payer evidence requirements are incorporated into clinical development plans
- Develop cross-functionally aligned, asset-specific patient-relevant outcomes strategies (disease conceptual model-informed)
- Support patient-relevant endpoint planning and implementation in clinical trials
- Lead early Joint Clinical Assessment (JCA) strategy development across markets (access implications/trade-offs)
- Assess payer evidence gaps and inform integrated evidence planning for early-stage assets
- Manage external partners (PRO development/validation, health state valuation, patient preference research)
- Support scientific interactions with HTA agencies (e.g., EU HTA JSC, NICE, CADTH) and prepare briefing materials/evidence packages (PRO endpoints, MCIDs, etc.)
- Support scientific interactions with regulatory agencies and patient advocacy organizations
- Partner with Integrated Evidence Teams to analyze patient-relevant outcomes data and strengthen value propositions
- Shape scientific communication; support publication/presentation in peer-reviewed journals
- Assess business development opportunities against payer/HTA requirements (risks, evidence gaps, access considerations)
Qualifications/Experience
- 7+ years pharma industry experience; 4+ years in HEOR (pharma or consulting); at least 2 years direct patient-relevant outcomes research
- Advanced degree in health economics/outcomes research/epidemiology/public health/health services research/pharmacy or related
Skills/Preferred
- Strong understanding of market access, value, and global HTA frameworks
- Experience developing/executing patient-relevant outcomes strategies for payer/HTA requirements
- Prior PRO measure evaluation/development/validation for regulatory/payer/HTA decisions
- Experience with HTA submissions, value dossiers, patient-relevant briefing books
- Ability to collaborate cross-functionally and prioritize multiple initiatives in a fast-paced environment
- Experience engaging external stakeholders (HTA agencies, payers, health economists, clinical experts, patient advocacy)
- Rare disease experience preferred
The Health Economics & Outcomes Research (HEOR) Associate Director supports asset-specific payer evidence strategies, including patient-relevant outcomes strategy, to generate differentiated evidence, strengthen the payer value proposition, and optimize access across a therapeutic area of interest. Leads patient-relevant outcomes requirements within clinical programs in alignment with Regulatory, HTA and access needs.
Responsibilities
- Lead development, execution and communication of payer evidence strategies for early-stage pipeline assets
- Collaborate with Value & Access, Commercial, Medical Affairs, Clinical Development, Regulatory Affairs, and Patient Advocacy
- Assess payer and HTA requirements for patient-relevant outcomes and health utility measurement
- Ensure payer evidence requirements are incorporated into clinical development plans
- Develop cross-functionally aligned, asset-specific patient-relevant outcomes strategies (disease conceptual model-informed)
- Support patient-relevant endpoint planning and implementation in clinical trials
- Lead early Joint Clinical Assessment (JCA) strategy development across markets (access implications/trade-offs)
- Assess payer evidence gaps and inform integrated evidence planning for early-stage assets
- Manage external partners (PRO development/validation, health state valuation, patient preference research)
- Support scientific interactions with HTA agencies (e.g., EU HTA JSC, NICE, CADTH) and prepare briefing materials/evidence packages (PRO endpoints, MCIDs, etc.)
- Support scientific interactions with regulatory agencies and patient advocacy organizations
- Partner with Integrated Evidence Teams to analyze patient-relevant outcomes data and strengthen value propositions
- Shape scientific communication; support publication/presentation in peer-reviewed journals
- Assess business development opportunities against payer/HTA requirements (risks, evidence gaps, access considerations)
Qualifications/Experience
- 7+ years pharma industry experience; 4+ years in HEOR (pharma or consulting); at least 2 years direct patient-relevant outcomes research
- Advanced degree in health economics/outcomes research/epidemiology/public health/health services research/pharmacy or related
Skills/Preferred
- Strong understanding of market access, value, and global HTA frameworks
- Experience developing/executing patient-relevant outcomes strategies for payer/HTA requirements
- Prior PRO measure evaluation/development/validation for regulatory/payer/HTA decisions
- Experience with HTA submissions, value dossiers, patient-relevant briefing books
- Ability to collaborate cross-functionally and prioritize multiple initiatives in a fast-paced environment
- Experience engaging external stakeholders (HTA agencies, payers, health economists, clinical experts, patient advocacy)
- Rare disease experience preferred